Micro-cost Analysis of ALK Rearrangement Testing by FISH to Determine Eligibility for Crizotinib Therapy in NSCLC: Implications for Cost Effectiveness of Testing and Treatment
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2014-12-01
|
| Series: | Clinical Medicine Insights: Oncology |
| Online Access: | http://www.la-press.com/micro-cost-analysis-of-alk-rearrangement-testing-by-fish-to-determine--article-a4554 |